| Join
Our Mailing List |
Keep up to date with all the news
and product releases from GeneraMedix Inc.
Join Now |
|
FDA
Consumer Site »
|
|
Our
Mission
The company’s mission is to bring to market generic
products where the active pharmaceutical ingredient
is difficult to source, significant manufacturing or
regulatory hurdles exist and are difficult to overcome,
or where product is in short supply.
Generic Injectables with
Vision
The company is led by a diverse and seasoned management
team who possess both the relationships and industry knowledge
to not only surmount these obstacles but also to create
a unique portfolio and drive the company forward. Each
team member has decades of pharmaceutical experience and
has worked for many of the major pharmaceutical companies
within the industry. The team is highly
motivated and continuously seeks ways to fulfill unmet
customer needs.
|
| |
|
|
|
 |
Ampicillin and Sulbactam
for Injection, USP
1.5 and 3 g in 10 and 15 mL
Vials, are now available. More » |
|
| |
|
|
|
Epirubicin Hydrochloride Injection
2 mg/mL in 25
and 100 mL Vials, are now available. More » |
|
| |
|
|
|
Fluorouracil Injection,
USP
50 mg/mL in 10, 20, 50 and 100 mL Vials, are now available. More » |
|
| |
|
|
|
Methotrexate Injection,
USP
25 mg/mL in 2, 10 and 40 mL Vials, are now available. More » |
|
|
| |
| |
|
|
November 28, 2007
GeneraMedix Inc announces FDA
approval for Epirubicin Hydrochloride Injection. More » |
|
| |
|
|
|
August 9, 2007
GeneraMedix Inc. Announces FDA
Approval and Launch of Ampicillin and Sulbactam for
Injection, USP. More » |
|
| |
|
|
|
August 8, 2007
GeneraMedix Inc.
launches Fosphenytoin Sodium Injection, USP. More » |
|
| |
|
|
|
August 7, 2007
GeneraMedix Inc. Announces FDA
Approval and Launch of Three Generic Injectable Products. More » |
|
| |
|
|
|
June 29, 2007
GeneraMedix Inc. receives FDA
approval for Ampicillin and Sulbactam for Injection,
USP. More » |
|
|
| |
|
